<< Sunday | Program and Abstracts | Tuesday >>
Room W184d
COMBINATION THERAPIES FOR OPTIMAL OBESITY TREATMENT
DDW Breakfast Connection, Sponsored by SSAT
| Faculty: |
Aurora D. Pryor, Providence, RI |
Session Objectives
Participants will be able to:
- Understand pharmacologic, endoscopic, and surgical treatment modalities for obesity and apply combination strategies to enhance weight?loss outcomes and long?term metabolic health.
Room W179a
PRESIDENTIAL ADDRESS
SSAT Legacy Session
2026 SSAT President
Gregory Kennedy, MD
Surgery, University of Alabama at Birmingham Health System Authority, Birmingham, AL
Room W179a
DORIS AND JOHN L. CAMERON GUEST ORATION
| Moderator: |
Gregory Kennedy, Birmingham, AL |
MINIMALLY INVASIVE SURGERY: REVOLUTION OR EVOLUTION?
Nathaniel J. Soper, MD
The University of Arizona College of Medicine Phoenix, Phoenix, AZ
Session Outline
The SSAT Cameron Oration is named in honor of John and Doris Cameron. Dr. John L. Cameron is a leader in gastrointestinal surgery and contributed greatly to many surgical organizations. His impact has been most substantial on the Society for Surgery of the Alimentary Tract. He served as SSAT President (1991-1992), received its highest honor, the SSAT Founder's Medal, and, perhaps most importantly, played a major role in establishing the SSAT's journal, the Journal of Gastrointestinal Surgery, which has risen to be one of the top GI surgical journals in the world. The SSAT is thrilled to celebrate John and Doris's contributions to the SSAT annually with the Cameron Oration at its Annual Meeting during DDW.
Room W181
PRACTICE CHANGING RESEARCH - HIGH IMPACT PAPERS 2026: SUMMARY AND CLINICAL REVIEW
DDW Combined Clinical Symposium, Sponsored by AGA, AASLD, ASGE, and SSAT
| Moderators: |
Douglas Robertson, White River Junction, VT Bubu Ama Banini, New Haven, CT |
Session Objectives
Participants will be able to:
- Review the most impactful research papers published in the field of gastroenterology, highlighting key findings and clinical implications.
- Explore significant studies in gastrointestinal endoscopy, focusing on advancements in diagnosis, treatment, and patient outcomes.
- Summarize groundbreaking research in hepatology, emphasizing innovative techniques and their impact on clinical practice.
GASTROENTEROLOGY
David Weinberg
Fox Chase Cancer Center, Philadelphia, PA
CLINICAL GASTRO AND HEPATOLOGY
Charles J. Kahi
Indiana University Health, Indianapolis, IN
HEPATOLOGY
Harmeet Malhi
Mayo Clinic, Rochester, MN
JOURNAL OF GASTROINTESTINAL SURGERY
Ali Tavakkoli
Brigham and Women's Hospital, Boston, MA
GASTROINTESTINAL ENDOSCOPY
Douglas E. Adler
AdventHealth, Denver, Colorado
Room W178b
SURGERY QUICK SHOT SESSION II
Abstract Presentations, DDW Surgery Track
Room W179a
PRESIDENTIAL PLENARY
| Moderator: |
Gregory Kennedy, Birmingham, AL |
View Live Session Details
REGIONAL NODAL STATUS INFLUENCES RECURRENCE PATTERNS FOLLOWING HEPATECTOMY FOR MULTIFOCAL INTRAHEPATIC CHOLANGIOCARCINOMA
Kever A. Lewis
1, Elena Panettieri
2, Galen Gist
1, Francesco Ardito
2, Mario De Bellis
3, Andrea Ruzzenente
3, Iolanda Scoleri
4, Emmanueal Boleslawski
4, Kristoffer W. Brudvik
5, Flavio Milana
6, Guido Torzilli
6, Guillauma Passot
7, Madhulika Eluri
1, Sunyoung S. Lee
1, Z. Ian Hu
1, Shubham Pant
1, Milind Javle
1, Adriana C. Gamboa
1, Yun Shin Chun
1, Ching-Wei D Tzeng
1, Felice Giuliante
2, Jean-Nicolas Vauthey
1, Hop S Tran Cao
1, Timothy E Newhook
1
1The University of Texas MD Anderson Cancer Center, Houston, TX, United States; 2Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Lazio, Italy; 3Azienda Ospedaliera Universitaria Integrata Verona Sede di Borgo Roma, Verona, Veneto, Italy; 4Centre Hospitalier Universitaire de Lille, Lille, Hauts-de-France, France; 5Oslo universitetssykehus, Oslo, Oslo, Norway; 6IRCCS Humanitas Research Hospital, Rozzano, Lombardia, Italy; 7Hospices Civils de Lyon, Lyon, Auvergne-Rhône-Alpes , France
NATURAL ORIFICE ENDOLUMINAL ENDOSCOPIC SURGERY (NOEES) FOR GALLBLADDER POLYPS: FEASIBILITY AND OUTCOMES OF A SINGLE-CENTER RETROSPECTIVE STUDY
Jian Guo Zhang
Peking University, Beijing, Beijing, China
AMERICAN JOINT COMMITTEE ON CANCER TUMOR REGRESSION GRADE AFTER NEOADJUVANT THERAPY: IMPLICATIONS FOR LONG-TERM OUTCOMES IN RECTAL CANCER
Michel Gardere Camargo, Scott Steele, Mikhael Belkovsky, Stefan D. Holubar, Michael Valente, Hermann Kessler, David Liska, Leonardo Duraes
Cleveland Clinic, Cleveland, OH, United States
THE IMPACT OF ANASTOMOTIC LEAK AFTER ESOPHAGECTOMY ON LONG-TERM SURVIVAL IN THE MODERN ERA OF MANAGEMENT (ALES STUDY): A MULTICENTER COHORT STUDY
Sheraz Markar, Lorenzo Giorgi, Nadia Guidozzi, Riadh Salem, Kerry Chou
John Radcliffe Hospital, Oxford, England, United Kingdom
MYELOID-SPECIFIC TLR4 SIGNALING DRIVES EARLY CYTOKINE SURGE AND CD4+ T-CELL CYTOTOXICITY THAT REDUCES PANCREATIC TUMOR BURDEN IN PRECLINICAL MODELS
Utpreksha Vaish
2,Suryansh Suryansh
2, Dhanisha sulekha Suresh
2, Maria Fernanda Noriega Salcedo
2, Abhiram Beena Kannan
2, Sweta Bhandari
2, Tejeshwar Jain
2, Srikanth Iyer
2, Vikas Dudeja
1
1Surgery, University of Iowa Health Care, Iowa City, IA, United States; 2The University of Alabama at Birmingham, Birmingham, AL, United States
EFFECTS OF A STANDARDIZED PANCREATIC EXOCRINE INSUFFICIENCY CARE PROTOCOL ON WEIGHT RECOVERY, CHEMOTHERAPY FEASIBILITY, AND ONCOLOGIC OUTCOMES AFTER PANCREATECTOMY
Poowanon Saksiri, Thakerng Pitakteerabundit, Tortrakoon Thongkan, Siriyupa Kaewbunsri, Ponlagrit Kumwichar
Prince of Songkla University Faculty of Medicine, Hat Yai, Songkhla, Thailand
TIME-DEPENDENT RECOVERY OF GASTRIC EMPTYING AFTER GASTRECTOMY: A 12-MONTH LONGITUDINAL STUDY USING A 13C-ACETATE BREATH TEST WITH A SEMI-SOLID MEAL
Sachiko Kaida
1, Katsushi Takebayashi
2,
1, Asuka Fukuo
1, Reiko Otake
1, Keiji Muramoto
1, Nobuhito Nitta
1, Soichiro Tani
1, Haruki Mori
1, Masatsugu Kojima
1, Hiromitsu Maehira
1, Toru Miyake
1, Mika Kurihara
2, Shigeki Bamba
3, Masaji Tani
1
1Surgery, Shiga Ika Daigaku, Otsu, Shiga Prefecture, Japan; 2Division of Clinical Nutrition, Shiga University of Medical Science, Otsu, Japan; 3Department of Fundamental Nursing, Shiga University of Medical Science, Otsu, Japan
VENTRAL HERNIA COMPLEXITY DOES NOT PREDICT FUNCTIONAL OUTCOMES: OBJECTIVE PERFORMANCE AND QUALITY OF LIFE FINDINGS FROM ABVENTURE-P
Sidhant Kalsotra
2, Mengda Yu
3, Kiana Shannon
2, Peter Edwards
2, Savannah Renshaw
2, Elanna Arhos
1, Lai Wei
3, Stephanie Di Stasi
4,
5, Ajit Chaudhari
5,
6,
7, Benjamin Poulose
2
1Department of Physical Therapy and Human Movement Sciences, Northwestern University, Evanston, IL, United States; 2The Ohio State University Department of Surgery, Columbus, OH, United States; 3Department of Biomedical Informatics, Center for Biostatistics, Ohio State University Wexner Medical Center, Columbus, OH, United States; 4The Ohio State University Division of Physical Therapy, Columbus, OH, United States; 5The Ohio State University Wexner Medical Center Sports Medicine Research Institute, Columbus, OH, United States; 6The Ohio State University School of Health and Rehabilitation Sciences, Columbus, OH, United States; 7Department of Biomedical Engineering, The Ohio State University, Columbus, OH, United States
LONG-TERM PROGNOSIS AND RECURRENCE RISK IN RESECTED NON-DUODENAL SMALL BOWEL ADENOCARCINOMA: A POST-HOC MULTICENTER STUDY
Toshio Kuwai
1, Yuki Kamigaichi
1, Shiro Oka
1, Takeshi Yamada
2, Keigo Mitsui
2, Hironori Yamamoto
3, Keiichi Takahashi
4, Akio Shiomi
5, Kinichi Hotta
5, Yoji Takauchi
6, Fumio Ishida
7, Shin-ei Kudo
7, Shoichi Saito
8, Masashi Ueno
9, Eiji Sunami
10, Tomoki Yamano
11, Michio Itabashi
12, Kazuo Ohtsuka
13, Yusuke Kinugasa
13, Takayuki Matsumoto
14, Tamotsu Sugai
14, Toshio Uraoka
15, Koichi Kurahara
16, Shigeki Yamaguchi
17, Tomohiro Kato
18, Masazumi Okajima
19, Hiroshi Kashida
20, Hiroaki Ikematsu
21, Masaaki Ito
21, Motohiro Esaki
22, Masaya Kawai
23, Takashi Yao
24, Takahiro Horimatsu
25, Yasumori Fukai
26, Yukihide Kanemitsu
27, Hiroyuki Takamaru
27, Kazutaka Yamada
28, Hiroaki Nozawa
29, Tetsuji Takayama
30, Kazutomo Togashi
31, Eiji Shinto
32, Takehiro Torisu
33, Naoki Ohmiya
34, Eigo Otsuji
36, Shinji Nagata
37, Yojiro Hashiguchi
38, Kenichi Sugihara
39, Yoichi Ajioka
40, Shinji Tanaka
35
1Hiroshima Daigaku Byoin, Hiroshima, Hiroshima, Japan; 2Nihon Ika Daigaku, Bunkyo, Tokyo, Japan; 3Jichi Ika Daigaku, Shimotsuke, Tochigi Prefecture, Japan; 4Grace Home Care Clinic, Ito, Shizuoka, Japan; 5Shizuoka Kenritsu Shizuoka Gan Center, Sunto District, Shizuoka Prefecture, Japan; 6Osaka Kokusai Gan Center, Osaka, Osaka Prefecture, Japan; 7Showa Medical University Northern Yokohama Hospital, Kanagawa, Japan; 8Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan; 9Toranomon Byoin, Minato, Tokyo, Japan; 10Kyorin University School of Medicine, Tokyo, Japan; 11Hyogo Ika Daigaku, Nishinomiya, Hyogo Prefecture, Japan; 12Tokyo Women's Medical University, Tokyo, Japan; 13Tokyo Kagaku Daigaku, Meguro, Tokyo, Japan; 14Iwate Ika Daigaku, Shiwa District, Iwate Prefecture, Japan; 15Gunma Daigaku Daigakuin Igakukei Kenkyuka Igakubu, Maebashi, Gunma Prefecture, Japan; 16Matsuyama Sekijuji Byoin, Matsuyama, Ehime Prefecture, Japan; 17Saitama Ika Daigaku Kokusai Iryo Center, Hidaka, Saitama Prefecture, Japan; 18Tokyo Jikeikai Ika Daigaku, Minato, Tokyo, Japan; 19Hiroshima Shiritsu Hiroshima Shimin Byoin, Hiroshima, Hiroshima Prefecture, Japan; 20Kinki Daigaku Byoin, Osakasayama, Osaka Prefecture, Japan; 21National Cancer Center Hospital East, Chiba, Japan; 22Saga Daigaku, Saga, Saga Prefecture, Japan; 23Juntendo Daigaku, Bunkyo, Tokyo, Japan; 24Juntendo University Graduate School of Medicine, Tokyo, Japan; 25Kyoto Daigaku Igakubu Fuzoku Byoin, Kyoto, Kyoto Prefecture, Japan; 26Maebashi Sekijuji Byoin, Maebashi, Gunma Prefecture, Japan; 27National Cancer Center, Goyang-si, Gyeonggi-do, Korea (the Republic of); 28Daicho Komonbyo Center Takano Byoin, Kumamoto, Kumamoto Prefecture, Japan; 29Tokyo Daigaku, Bunkyo, Tokyo, Japan; 30Tokushima Daigaku Daigakuin Ishiyakugaku Kenkyubu, Tokushima, Tokushima Prefecture, Japan; 31Fukushima Kenritsu Ika Daigaku Aizu Iryo Center, Aizuwakamatsu, Fukushima Prefecture, Japan; 32Boei Ika Daigakko, Tokorozawa, Saitama Prefecture, Japan; 33Kyushu Daigaku, Fukuoka, Fukuoka Prefecture, Japan; 34Fujita Ika Daigaku Igakubu Daigakuin Igaku Kenkyuka, Toyoake, Aichi Prefecture, Japan; 35JA Onomichi Sogo Byoin, Onomichi, Hiroshima Prefecture, Japan; 36Kyoto Furitsu Ika Daigaku, Kyoto, Kyoto Prefecture, Japan; 37Hiroshima Shiritsu Asa Shimin Byoin, Hiroshima, Hiroshima Prefecture, Japan; 38Japanese Red Cross Omori Hospital, Tokyo, Japan; 39Tokyo Kagaku Daigaku, Meguro, Tokyo, Japan; 40Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan
Room W184bc
SSAT-AHPBA: PUBLICS' HEPATOBILIARY SURGICAL BAILOUTS
SSAT Joint Symposium, Americas Hepato-Pancreato-Biliary Association
| Moderators: |
Timothy E. Newhook, Houston, TX Shimul Shah, Boston, MA Tara S. Kent, Boston, MA |
Session Outline
This symposium on complex hepatobiliary situations will focus on practical bailout strategies when standard approaches are not feasible or have failed. Through real world scenarios, experts will review surgical and nonsurgical options for the hostile gallbladder, challenging biliary disease, and stone disease after bariatric surgery, as well as management of gastric outlet obstruction from both surgical and endoscopic perspectives. The session will also cover multidisciplinary approaches to bile leaks and strictures, including cases after hepatic artery infusion pump therapy, highlighting how coordinated care across surgery, endoscopy, and interventional radiology can improve patient outcomes.
Session Objectives
Participants will be able to:
- Recognize bailout scenarios: Identify clinical situations in hepatobiliary disease where standard surgical approaches are high risk, infeasible, or unsuccessful, and bailout strategies are required
- Compare multidisciplinary options: Describe the roles of surgical, endoscopic, and interventional radiology approaches in managing hostile gallbladders, complex biliary disease, post bariatric stone disease, and gastric outlet obstruction.
- Apply strategies to complications: Review evidence based approaches to bile leaks and biliary strictures, including after HAIP therapy, and incorporate multidisciplinary decision making to optimize outcomes
THIS IS A BOMB! SURGICAL BAILOUTS FOR THE HOSTILE GALLBLADDER
Erin Baker
Atrium Health, Charlotte, NC
NON-SURGICAL BAILOUTS IN THE PATIENT WITH BILIARY DISEASE
Uzma D. Siddiqui
Center for Endoscopic Research and Therapeutics (CERT), Unversity of Chicago, Chicago, IL
MANAGEMENT OF POST-BARIATRIC STONE DISEASE
Rohan Jeyarajah
Methodist Health System, Dallas, TX
GOO - WHAT TO DO?: SURGICAL SOLUTIONS
Ching-Wei D. Tzeng
Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
GOO - WHAT TO DO?: ENDOSCOPIC SOLUTIONS
Mustafa A. Arain
Medicine, AdventHealth Orlando, Orlando, FL
Q&A
Room W181
THE LONG AND WINDING ROAD: PRACTICAL SOLUTIONS FOR COMMON DISORDERS OF SMALL BOWEL
DDW Combined Clinical Symposium, Sponsored by SSAT, ASGE, AGA
| Moderators: |
Shirley Paski, Cleveland, OH Viveksandeep Thoguluva Chandrasekar, Augusta, GA |
Session Outline
This session will focus on advanced small bowel endoscopic interventions, highlighting both established and emerging techniques. Expert faculty will discuss device-assisted enteroscopy approaches for managing small bowel bleeding, strictures, polyps, and foreign bodies. Special emphasis will be placed on polypectomy, balloon dilation, and hemostasis.
Session Objectives
Participants will be able to:
- Understand the indications and techniques for therapeutic small bowel enteroscopy
- Review advanced interventions such as polypectomy, stricture dilation, hemostasis, and foreign body retrieval
- Discuss novel applications: EUS-guided small bowel access, stent placement, and deep enteroscopy-assisted ERCP Address training, complication management, and future innovations
DEVICE ASSISTED ENTEROSCOPY: APPROACHES, EQUIPMENT, AND ACCESS STRATEGIES
Rajiv Chhabra
CAPSULES, SCOPES, AND SCANS: EVALUATION BEYOND THE DUODENUM
Suryakanth Gurudu
ENDOSCOPIC MANAGEMENT OF SMALL BOWEL STRICTURES: BALLOON DILATION AND BEYOND?
Erin M. Forster
CHRONIC DIARRHEA OF SMALL BOWEL ORIGIN: WHAT TO LOOK FOR?
Millie D. Long
SHORT GUT, LONG TERM CARE: CONSEQUENCES AND APPROACH TO SHORT BOWEL SYNDROME?
Jamie Murphy
Abstract Presentations, SSAT Video Session
Room W185d
ACUTE TO CHRONIC CHOLECYSTITIS AND EVERYTHING IN BETWEEN
DDW Meet-the-Professor Luncheon, Sponsored by SSAT
| Faculty: |
R. Matthew Walsh, Cleveland, OH Eduardo Montalvo-Javé, Mexico City, Mexico |
Session Objectives
Participants will be able to:
- Understand diagnostic and management strategies across the full disease spectrum
Poster Hall, Level 3, Hall F2
VISIT POSTER HALL, VIEW EXHIBITS (NON-CME)
| SSAT Moderators: |
Allison N. Martin, Houston, TX Reed I. Ayabe, Houston, TX Alex M. Roch, Indianapolis, IN |
Surgery Poster Groups:
Novel and Experimental Surgical Techniques & Surgery in Pediatric Patients,
Surgery Track
Surgery Health Services Research & Quality Measures and Quality Improvement,
Surgery Track
Surgical Complications,
Surgery Track
Training and Education for Surgery,
Training and Education Track
Training and Education for Surgery and Endoscopy,
Training and Education Track
Pancreatic Surgery,
Pancreas Track
Gastroduodenal Surgery,
Stomach & Duodenum Track
Peritoneal/Abdominal Wall/Small Bowel (PAWS) Surgery,
Small Intestine Track
Authors available at their posters to answer questions 12:30 pm - 1:30 pm; posters on display 9:30 AM - 4 PM.
Room W179a
OPTIMIZING PERIOPERATIVE CARE IN GASTROINTESTINAL SURGERY - PREHABILITATION AND PERSONALIZED APPROACHES
SSAT Symposium, International Outreach Committee
| Moderators: |
Taylor S. Riall, Tucson, AZ Tania Triantafyllou, Athens, Greece Ulysses Ribiero, São Paulo, Brazil |
PERIOPERATIVE ASSESSMENTS AND PATIENT REPORTED OUTCOMES - WHAT DO WE NEED TO KNOW?
Ulysses Ribeiro
Gastroenterology, University of São Paulo, São Paulo, SP, Brazil
NUTRITION AND PERIOPERATIVE OUTCOMES - INDIVIDUAL PATIENT-CENTERED CONCEPTS
Ming-Tsan Lin
NTU, Taipei, Taiwan
PREHABILITATION - WHAT WE NEED TO IMPLEMENT AND WHAT STILL NEEDS TO BE PROVEN
Louisa Bolm
Department of Surgery, Massachusetts General Hospital, Boston, MA
HOW TO IMPLEMENT ERAS AND PREHABILITATION- WHAT IS FEASIBLE
Carrie Luu
Surgery, Saint Louis University Hospital, St Louis, MO
CASE PRESENTATION 1: FRAIL PATIENT WITH CACHEXIA PLANNED FOR MULTIMODAL SURGICAL-ONCOLOGICAL THERAPY
Francisco Tustumi
Gastroenterologia, USP, São Paulo, SP, Brazil
CASE PRESENTATION 2:?OBESE PATIENT WITH LIMITED DAILY ACTIVITY LEVEL AND CO-MORBIDITIES
Saumya Singh
Surgery, King George's Medical University, Lucknow, Uttar Pradesh, India
Room W181
COMPREHENSIVE APPROACHES TO OBESITY MANAGEMENT: PHARMACOLOGIC, ENDOSCOPIC, AND SURGICAL PERSPECTIVES
DDW Combined Clinical Symposium, Sponsored by SSAT, AASLD, ASGE, AGA
| Moderators: |
Catherine T. Hudson, New Orleans, LA Mazen Noureddin, Houston, TX Aurora D. Pryor, Providence, RI |
Session Outline
This session will focus on advanced small bowel endoscopic interventions, highlighting both established and emerging techniques. Expert faculty will discuss device-assisted enteroscopy approaches for managing small bowel bleeding, strictures, polyps, and foreign bodies. Special emphasis will be placed on polypectomy, balloon dilation, and hemostasis.
Session Objectives
Participants will be able to:
- Understand the indications and techniques for therapeutic small bowel enteroscopy
- Review advanced interventions such as polypectomy, stricture dilation, hemostasis, and foreign body retrieval
- Discuss novel applications: EUS-guided small bowel access, stent placement, and deep enteroscopy-assisted ERCP Address training, complication management, and future innovations
CURRENT PHARMACOLOGICAL MANAGEMENT OF OBESITY (FDA APPROVED THERAPIES)
Robert Kushner
Northwestern Feinberg School Of Medicine, Chicago, IL
EMERGING PHARMACOTHERAPIES FOR OBESITY: PIPELINE AND FUTURE DIRECTIONS
Lee Kaplan
Massachusetts General Hospital, Boston, MA
ADVANCES IN ENDOSCOPIC MANAGEMENT OF OBESITY
Rahul Pannala
Mayo Clinic, Scottsdale, AZ
SURGICAL MANAGEMENT OF OBESITY: CURRENT ROLE AND FUTURE OUTLOOK
John Morton
Yale University School of Medicine, Madison, CT
Room W178b
SMALL BOWEL AND COLORECTAL
Abstract Presentations, SSAT Video Session
Room W375c
EPIDEMIOLOGY AND OUTCOMES OF SURGERY IN IBD
Abstract Presentations, DDW Inflammatory Bowel Diseases Track
Room W179a
KELLY AND CARLOS PELLEGRINI SSAT-SAGES: ANTIREFLUX SURGERY IN 2026 - PATIENT SELECTION, RISK FACTORS, AND OPTIMIZING OUTCOMES
SSAT Joint Symposium, Society of American Gastrointestinal and Endoscopic Surgeons
| Moderators: |
Mary Hawn, Stanford, CA Dana Telem, Ann Arbor, MI |
Session Outline
As the indications for antireflux surgery expand and the landscape of GERD management evolves, optimizing outcomes depends increasingly on thoughtful patient selection and individualized decision-making. This session will explore key clinical and physiologic factors that influence surgical success - including BMI, gastroparesis, esophageal motility, and functional symptom overlap. Through expert insights and evidence-based discussion, the panel will address how to identify appropriate candidates, tailor procedural choices, and define meaningful outcomes in 2026 and beyond.
Session Objectives
Participants will be able to:
- Identify key patient-specific factors - such as BMI, gastroparesis, and functional symptoms - that influence outcomes after antireflux surgery.
- Understand how esophageal physiologic testing (HRM and FLIP) can guide patient selection and procedural planning.
- Apply evidence-based strategies to optimize patient satisfaction and long-term success following antireflux surgery.
FUNCTIONAL AND BEHAVIORAL PITFALLS: WHEN ANTIREFLUX SURGERY ISN'T THE ANSWER
Anne O. Lidor
Surgery, University of Wisconsin-Madison, Madison, WI
NAVIGATING BMI IN ANTIREFLUX SURGERY: OUTCOMES, THRESHOLDS, AND PROCEDURAL CHOICE
Guilherme Campos
Virginia Commonwealth University, Richmond, VA
GASTROPARESIS AND ANTIREFLUX SURGERY: RISK FACTOR FOR FAILURE OR MISUNDERSTOOD COMORBIDITY?
Tanuja Damani
New York University, New York, NY
GUIDING ANTIREFLUX SURGERY WITH HRM AND FLIP: FROM EVALUATION TO EXECUTION
Yalini Vigneswaran
Surgery, University of Chicago Division of the Biological Sciences, Chicago, IL
Room W184bc
INNOVATION IN APPS FOR THE CARE OF THE GI PATIENT
SSAT Symposium, Advanced Practice Providers Committee
| Moderators: |
Monica Zablotney, Madison, WI Margaret Gardner, Pittsburgh, PA |
Session Outline
The panel of Advanced Practice Providers (APPs) in GI Surgery demonstrates utilization of APPs in innovative ways across the surgery continuum. From the initial point of contact to discharging a patient from formal care, APP practice has bolstered the patient experience along with surgical technology and training to improve patient experience. During this session, the patient experience is broken down (pre-operative state, inpatient experience and outpatient recovery) to demonstrate how APP utilization can augment surgical practice through advancing scope of practice, utilization of technology and tools to reach beyond the hospital to patients.
Session Objectives
Participants will be able to:
- Apply principles of clinical innovation in surgical settings to improve access, patient care and efficiency in operative planning
- Leveraging technology to assist in bridging gaps in the care continuum and identifying APP value in practice
- Identify opportunities for APP utilization to improve communication, patient education, or care transitions that impact surgical outcomes
APP IMPACT OF SURGERY VISIT OPTIMIZATION
Jennifer Merrill
Surgery, Medical College of Wisconsin, Milwaukee, WI
CLINICAL DOCUMENTATION INTEGRITY- CAPTURING APP SCOPE OF PRACTICE
Sarah A. Smith
Medicine, University of Pennsylvania, Philadelphia, PA
CARE BEYOND THE HOSPITAL: APP CONTINUITY POST-DISCHARGE
Chelsea Wozniak
Banner Health, Phoenix, AZ
APP RESEARCH GRANT AWARD PRESENTATION
Room W375d
IBD: DELIBERATING ON DYSPLASIA
DDW Combined Clinical Symposium, Sponsored by SSAT, ASGE, AGA
| Moderators: |
Jennifer S. Davids, Boston, MA Fernando Velayos, San Francisco, CA |
Session Objectives
Participants will be able to:
- Broaden knowledge on longitudinal cancer risk in IBD patients
- Understand data regarding endoscopic and surgical management of colonic dysplasia
- Recognize advances in endoscopic surveillance techniques
LONGITUDINAL CANCER RISK: KNOW YOUR NUMBERS
Nayantara Coelho-Prabhu
Mayo Clinic Rochester, Rochester, MN
SEGMENTAL VS. TOTAL PROCTOCOLECTOMY
Ira Leeds
Yale School of Medicine, New Haven, CT
WHEN TO OPERATE FOR LGD AND HGD
Olga Beresneva
Boston Medical Center, Boston, MA
STATE-OF-THE-ART OPTIONS FOR ENDOSCOPIC SURVEILLANCE
Erin M. Forster
Medical University of South Carolina, Charleston, SC
HOW TO MANAGE DYSPLASTIC LESIONS
Emmanuel Coronel
The University of Texas MD Anderson Cancer Center, Houston, TX
Room W180
DDW SHARK TANK (NON-CME)
DDW Symposium, Sponsored by AGA, AASLD, ASGE, SSAT
| Moderators: |
Michael L. Kochman, Philadelphia, PA Andrea Vossler, Buffalo, NY |
WELCOME AND SHARK TANK INTRODUCTIONS
Michael L. Kochman, Andrea Vossler
AASLD SHARK
Joseph Ahn
Endeavor Health, Niles, IL
AGA SHARK
Scott Fraser
Fraser Healthcare, LLC, Malvern, PA
ASGE SHARK
Jonathan Cohen
NYU Langone School of Medicine, New York, NY
SSAT SHARK
Trang K. Nguyen
Indiana University School of Medicine, Indianapolis, IN
SSAT INNOVATOR
Ting-Chun Kuo
National Taiwan University Hospital, Taipei, Taiwan
ASGE INNOVATOR
Moaz Sial, Huzaifa Sial
Cedar Valley Digestive Healthcare Center, Waterloo, IA
AASLD INNOVATOR
Philip Vutien
University of Washington, Seattle, WA
AGA INNOVATOR
TBD
<< Sunday | Program and Abstracts | Tuesday >>